UiPath (NYSE:PATH – Free Report) had its price objective cut by Scotiabank from $15.00 to $12.00 in a research report report ...

UiPath (NYSE:PATH – Free Report) had its price target decreased by Morgan Stanley from $16.00 to $12.00 in a report published ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

ARK also bought 79,201 shares of IBOTTA INC (NASDAQ:IBTA) across its ARKW and ARKF ETFs, with a total value of approximately $3.17 million. Notably, this purchase adds to ARK’s ongoing accumulation of ...

BMO Capital analyst Keith Bachman lowered the firm’s price target on UiPath (PATH) to $11.50 from $16 and keeps a Market Perform rating on the ...

UiPath (NYSE:PATH) saw its stock plummet over 14% intra-day today after delivering a disappointing revenue forecast for ...

The U.S. market has been on the back foot since the middle of February, as President Donald Trump’s tariff policy has sunk ...

The semiconductor company named Lip-Bu Tan, a former board m ...

Learn more about whether Open Text Corporation or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Manhattan Associates, Inc. or UiPath Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Dow, S&P 500, and Nasdaq fell Thursday as the stock market digested the latest economic data and Trump's response to Canada and EU tariffs. The S&P 500 closed in correction territory.

UiPath, Inc. (NYSE: PATH) shares are trading lower Thursday after the company reported fourth-quarter revenue and issued ...